31![Microsoft Word - PRTX_SCIR.doc Microsoft Word - PRTX_SCIR.doc](https://www.pdfsearch.io/img/2b7ae3e1405ca2449ce315dfad383129.jpg) | Add to Reading ListSource URL: scr.zacks.comLanguage: English - Date: 2013-09-16 11:37:44
|
---|
32![Approaches in Clinical Development for Chronic Inflammatory Diseases A Case Study in Rheumatoid Arthritis Worldwide Clinical Trials’ Experience in Chronic Inflammatory Diseases Chronic inflammatory diseases represent c Approaches in Clinical Development for Chronic Inflammatory Diseases A Case Study in Rheumatoid Arthritis Worldwide Clinical Trials’ Experience in Chronic Inflammatory Diseases Chronic inflammatory diseases represent c](https://www.pdfsearch.io/img/b78c2515900f6f9ae212e861259401d3.jpg) | Add to Reading ListSource URL: www.wwctrials.comLanguage: English - Date: 2011-10-12 16:32:48
|
---|
33![Label - Anakinra (Kineret), Amgen Label - Anakinra (Kineret), Amgen](https://www.pdfsearch.io/img/53c87312a0f18e5413aaa7922595edec.jpg) | Add to Reading ListSource URL: www.accessdata.fda.govLanguage: English - Date: 2009-03-31 16:07:19
|
---|
34![Update On Infections and Anti-TNF Drugs Update On Infections and Anti-TNF Drugs](https://www.pdfsearch.io/img/a3af5b471beff01e301803f6cfbdffbd.jpg) | Add to Reading ListSource URL: www.vfce.arizona.eduLanguage: English - Date: 2011-11-18 10:04:10
|
---|
35![SUPPLEMENTARY INFORMATION Supplementary methods Study endpoints Secondary and exploratory endpoints included: other remission rates (Simplified Disease Activity Index [SDAI; ≤3.3], Clinical Disease Activity Index [CDAI SUPPLEMENTARY INFORMATION Supplementary methods Study endpoints Secondary and exploratory endpoints included: other remission rates (Simplified Disease Activity Index [SDAI; ≤3.3], Clinical Disease Activity Index [CDAI](https://www.pdfsearch.io/img/b98b99710a2d8257f30673caf98a915d.jpg) | Add to Reading ListSource URL: ard.bmj.comLanguage: English - Date: 2014-11-03 11:27:25
|
---|
36![1 SUPPLEMENTAL MATERIALS 2 1 SUPPLEMENTAL MATERIALS 2](https://www.pdfsearch.io/img/e5f1ed8ceba21a71ad4cb2aaaaaaf49f.jpg) | Add to Reading ListSource URL: ard.bmj.comLanguage: English - Date: 2014-08-30 01:12:35
|
---|
37![An Independent Licensee of the Blue Cross and Blue Shield Association Prior Authorization Requirements Effective: [removed] An Independent Licensee of the Blue Cross and Blue Shield Association Prior Authorization Requirements Effective: [removed]](https://www.pdfsearch.io/img/e89e8da4987bd68819c647be9567fc41.jpg) | Add to Reading ListSource URL: www.azbluemedicare.comLanguage: English - Date: 2014-11-26 15:58:03
|
---|
38![Health and Community Services The Newfoundland and Labrador Prescription Drug Program CRITERIA FOR THE COVERAGE OF SPECIAL AUTHORIZATION DRUGS Subject to revision Coverage of special authorization drugs will be approved Health and Community Services The Newfoundland and Labrador Prescription Drug Program CRITERIA FOR THE COVERAGE OF SPECIAL AUTHORIZATION DRUGS Subject to revision Coverage of special authorization drugs will be approved](https://www.pdfsearch.io/img/a5ebff6347ff509bdedc95b631a58b05.jpg) | Add to Reading ListSource URL: www.health.gov.nl.caLanguage: English - Date: 2014-11-07 11:38:22
|
---|
39![ANTIRHEUMATIC DRUGS Compiled by Dr. Joel Kremer (Updated Nov[removed]Weinblatt ME, Kremer JM, Coblyn JS, Maier AL, Helfgott SM, Morell M, Byrne VM, Kaymakcian MV, Stand V. Efficacy, Safety, and pharmacokinetics of the ANTIRHEUMATIC DRUGS Compiled by Dr. Joel Kremer (Updated Nov[removed]Weinblatt ME, Kremer JM, Coblyn JS, Maier AL, Helfgott SM, Morell M, Byrne VM, Kaymakcian MV, Stand V. Efficacy, Safety, and pharmacokinetics of the](https://www.pdfsearch.io/img/fe899aaf58abd6682adc33066ea133ef.jpg) | Add to Reading ListSource URL: www.rheumatology.orgLanguage: English |
---|
40![HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use AUBAGIO® safely and effectively. See full prescribing information for AUBAGIO. AUBAGIO (teriflunomide) tablets, for HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use AUBAGIO® safely and effectively. See full prescribing information for AUBAGIO. AUBAGIO (teriflunomide) tablets, for](https://www.pdfsearch.io/img/7ec0c689aeefd8b667a8f1b8e5291317.jpg) | Add to Reading ListSource URL: www.accessdata.fda.govLanguage: English - Date: 2014-10-20 12:56:41
|
---|